n/a
Article Publish Status: FREE
Abstract Title:

3,3-Diindolylmethane (DIM): A nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial.

Abstract Source:

Carcinogenesis. 2020 May 27. Epub 2020 May 27. PMID: 32458980

Abstract Author(s):

Rinat Yerushalmi, Sharon Bargil, Yaara Bar, Rachel Ozlavo, Sivan Tuval, Yael Rapson, Adi Pomerantz, Dalia Zoref, Eran Sharon, Opher Caspi, Ahuvah Grubsrein, David Margel

Article Affiliation:

Rinat Yerushalmi

Abstract:

Women who carry the BRCA mutation are at high lifetime risk of breast cancer, but there is no consensus regarding an effective and safe chemoprevention strategy. A large body of evidence suggests that 3,3-diindolylmethane (DIM), a dimer of indole-3-carbinol (I3C) found in cruciferous vegetables, can potentially prevent carcinogenesis and tumor development. The primary aim of this prospective single-arm study was to investigate the effect of DIM supplementation on breast density, a recognized predictive factor of breast-cancer risk. Participants were 23 healthy female BRCA carriers (median age 47 years; 78% postmenopausal) who were treated with oral DIM 100 mgx1/d for one year. The amount of fibroglandular tissue (FGT) and background parenchymal enhancement (BPE) on magnetic resonance imaging (MRI) performed before and after the intervention were scored by two independent expert radiologists using the Breast Imaging and Reporting Data System (BI-RADS). The results showed a decrease in the average score for FGT amount from 2.8±0.8 at onset to 2.65±0.842.8 after one year (p=0.031), with no significant change in BPE (p=0.429). A group of DIM-untreated age- and menopausal-status-matched clinic women did not show a significant change in FGT amount (p=0.33) or BPE (p=0.814) in a parallel year. Mean estradiol level decreasedfrom 159 to 102 pmol/L (p=0.01), and mean testosterone level, from 0.42 to 0.31 pmol/L (p=0.007). Side effects were grade 1. In conclusion, one year's supplementation with DIM 100 mgX1/d in BRCA carriers was associated with a significant decline in FGT amount on MRI. Larger randomized studies are warranted to corroborate these findings.

Study Type : Human Study
Additional Links
Additional Keywords : BRCA Gene : CK(38) : AC(7)

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.